Learn / RCUS
NYSE: RCUS
Arcus Biosciences (RCUS) stock, explained like you're 5
Arcus Biosciences trades on the New York Stock Exchange under the ticker RCUS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.1 billion dollars.
- Ticker
- RCUS
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 3.1 billion dollars
Is Arcus Biosciences a small, medium or large cap company?
No. Arcus Biosciences is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Arcus Biosciences makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves RCUS stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Missed Arcus Biosciences' Rally? Here's What Early Buyers Saw (Simply Wall Street)
- Arcus Biosciences (RCUS) to Present Kidney Cancer Drug Data in U (GuruFocus)
- Arcus Biosciences, Inc. (RCUS) Stock Forecasts (Yahoo Finance)
- JPMorgan initiates Arcus Biosciences stock at Overweight, $41 target (Investing.com)
- Top Arcus Biosciences (RCUS) Competitors 2026 (MarketBeat)
Follow RCUS in your daily brief
Each trading day at 5 PM ET we post what happened to Arcus Biosciences and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow RCUS
Questions about Arcus Biosciences stock
What does Arcus Biosciences do?
Arcus Biosciences trades on the New York Stock Exchange under the ticker RCUS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.1 billion dollars.
What is the ticker symbol for Arcus Biosciences?
Arcus Biosciences trades under the ticker RCUS on the New York Stock Exchange.
What is Arcus Biosciences's market cap?
Arcus Biosciences is a mid cap stock with a market cap of about 3.1 billion dollars.
How does Arcus Biosciences make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves RCUS stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow RCUS stock every day?
Add RCUS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.